Tissue transglutaminase (tTG) is an indicator of acute cell death in vitro. An increase in tTG protein level is found in postmortem Alzheimer's disease (AD) brains as well as in Huntington's disease. No study revealed tTG in vivo so far. We investigated the concentrations of tTG in the cerebrospinal fluid (CSF) obtained from 84 patients using ELISA assays. We compared 33 patients with probable AD to 18 patients with probable vascular dementia (VaD) and 33 control patients without neuropsychological deficit. Diagnosis was supported by CSF parameter and neuroimaging. We found a highly significant difference (P ‫؍‬ 0.001) between the concentration of tTG in the AD groups (7.58 pg/ml) and controls (2.99 pg/ml). There was no statistical difference between controls and VaD (2.93 pg/ml). Interestingly, tTG did not show an association with tau protein, A␤42, apoE4, neuropsychological items, or age. Males showed lower tTG values than females; however, this difference did not reach statistical significance. To our knowledge, this is the first demonstration that tTG is increased in AD in vivo. Our results suggest that tTG may be a powerful biochemical marker of the acute degenerating process in vivo. It may serve as completion of CSF analysis in the diagnosis of dementing disorders and may be a simple way of assessing the efficacy of possible new antiapoptotic drugs. © 2002 Elsevier Science (USA)
INTRODUCTION
Alzheimer's disease (AD), 2 the most common agerelated neurodegenerative disorder, is associated with the selective damage of brain regions and neural circuits. Dysfunction and loss of neurons in these neural circuits result in impaired memory, thinking, and behavior. Two major defining hallmarks of AD pathology are the intraneuronal neurofibrillary tangles and the extracellular neuritic senile plaques. Both of these lesions are formed by abnormally polymerized proteins in the brain, and both are extremely insoluble structures. Purification and analysis have demonstrated that senile plaques contain amyloid fibrils composed of the amyloid ␤-protein 42 (A␤42) (Kang et al., 1987; Masters et al., 1985) . Neurofibrillary tangles are composed primarily of paired helical filaments (PHF) (Delacourte & Defossez, 1986; Kosik et al., 1986) , and a major component of these PHF is the hyperphosphorylated form of the microtubule-associated protein tau (Goedert et al., 1992; Lee et al., 1991) . It has been hypothesized that tissue transglutaminase (tTG) may be involved in the pathogenesis of AD by facilitating the formation of one or both of these insoluble lesions (Grierson et al., 2001; Johnson et al., 1997; Lesort et al., 2000) . TTG may also contribute to the etiology of other neurodegenerative disorders like Huntington's 1 To whom correspondence should be addressed. Fax: ϩϩ43-316-5989-2380. E-mail: rm.bonelli@nextra.at. 
